First Quarter of Fiscal Year Ended Mar. 2023
- Key metrics (PDF / 114KB)
- Composition of Capital Disclosure (PDF / 112KB)
- Reconciliation of regulatory capital to the balance sheet (PDF / 51KB)
- Overview of RWA (PDF / 69KB)
- RWA flow statements of credit risk exposures under IRB (PDF / 23KB)
- RWA flow statements of market risk exposures under IMA (PDF / 24KB)
- Composition of Leverage Ratio (PDF / 128KB)
- Liquidity Coverage Ratio (PDF / 42KB)
- Net Stable Funding Ratio (PDF / 84KB)
- Main features of regulatory capital instruments
Regulatory capital instruments (TLAC eligible)
Eligible capital instruments under transitional treatment (not TLAC eligible (note))
- Can be counted in external and internal TLAC by 2022/3/30 as FSB's transitional treatment